Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.97), $0.15 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $119 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.